Immunocore Holdings plc (IMCR) Misses Q3 EPS by 31c

Immunocore Holdings plc (NASDAQ: IMCR) reported Q3 EPS of ($0.59), $0.31 worse than the analyst estimate of ($0.28). Revenue for the quarter came in at $51.49 million versus the consensus estimate of $50.69 million.

For earnings history and earnings-related data on Immunocore Holdings plc (IMCR) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79